-
公开(公告)号:HK1050186A1
公开(公告)日:2003-06-13
申请号:HK03102394
申请日:2003-04-03
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , FOURQUEZ JEAN-MARIE , LEVENS NIGEL , HUSSON-ROBERT BERNADETTE , NOSJEAN OLIVIER , BOULANGER MICHELLE
IPC: C07D295/18 , A61K31/16 , A61K31/397 , A61K31/40 , A61K31/403 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/04 , C07D277/22 , C07D295/185 , C07C , C07D , A61K , A61P
Abstract: A compound of formula (I):wherein:represents an optionally substituted saturated carbon ring having from 4 to 8 ring members,R1 and R4, which may be identical or different, each represents hydrogen or acyl,R2 and R3, which may be identical or different, each represents hydrogen or alkyl,R5 and R6, which may be identical or different, each represents hydrogen or alkyl, or R5 and R6 together, with the nitrogen atom carrying them, form an optionally substituted nitrogen-containing heterocycle,stereoisomers thereof, and also addition salts thereof with a pharmaceutically acceptable acid.Medicinal products containing the same which are useful for treatment of glucose intolerance or of disorders associated with hyperglycaemia.
-
公开(公告)号:ES2187334A1
公开(公告)日:2003-06-01
申请号:ES200100105
申请日:2001-01-17
Applicant: SERVIER LAB
Inventor: MONGE VEGA ANTONIO , ALDANA MORAZA IGNACIO , CAIGNARD DANIEL-HENRI , LEVENS NIGEL , FELETOU MICHEL , DELLA ZUABA ODILE
IPC: A61P3/04 , C07C311/13 , C07C311/19 , C07D213/82 , C07D215/36 , C07D333/34 , C07C311/18 , A61K31/15 , A61K31/18 , C07C311/05
Abstract: Nuevos derivados de la hidrazida, su procedimiento de preparación y las composiciones farmacéuticas que los contienen Compuestos de fórmula (I): R-NH-A-CO-NH-NH-(W){sub,n }-Z en la cual: - n equivale a 0 ó a 1, - W representa un grupo -CO- o un grupo S(O){sub,r} en el cual r equivale a 0, 1 ó 2, - Z representa un grupo seleccionado entre arilo, arilalquilo, heteroarilo heteroarilalquilo eventualmente sustituidos, y alquilo, - R representa un grupo seleccionado entre: Z{sub,1}-T-CO-,Z{sub,1}- O-T-CO-,Z{sub,1}-T-O-CO-,Z{sub,1}-T-S(O){sub,q}- en los cuales Z{sub,1}, T y q son tales como se han definido en la descripción, - A representa un grupo alquileno, alquenileno o alquinileno de 3 a 8 átomos de carbono, alquilencicloalquilenalquileno, alquilenarileno, arilenalquileno, alquilenarilenalquileno, un grupo **FIGURA-01** en el cual B{sub,1} es tal como se ha definido en la descripción, o bien A forma con el átomo de nitrógeno adyacente un grupo **FIGURA- 02** tal como se ha definido en la descripción. Medicamentos.
-
公开(公告)号:NO20031643A
公开(公告)日:2003-04-10
申请号:NO20031643
申请日:2003-04-10
Applicant: SERVIER LAB
Inventor: FAUCHERE JEAN-LUC , ORTUNO JEAN-CLAUDE , LEVENS NIGEL , CHAMORRO SUSANA , BOUTIN JEAN-ALBERT
IPC: C07D249/14 , A61K31/4196 , A61K31/422 , A61K31/428 , A61K31/4439 , A61K31/4709 , A61K31/55 , A61P3/00 , A61P3/04 , A61P3/10 , A61P9/12 , A61P15/10 , A61P25/08 , A61P25/20 , A61P25/22 , A61P25/24 , A61P43/00 , C07D401/04 , C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/04 , A61D9/12
CPC classification number: C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12
-
公开(公告)号:FR2830012A1
公开(公告)日:2003-03-28
申请号:FR0112205
申请日:2001-09-21
Applicant: SERVIER LAB
Inventor: LESIEUR DANIEL , BLANC DELMAS ELODIE , BENNEJEAN CAROLINE , CHAVATTE PHILIPPE , GUILLAUMET GERALD , DACQUET CATHERINE , LEVENS NIGEL , BOUTIN JEAN ALBERT , RENARD PIERRE
IPC: A61P3/10 , A61P9/10 , A61P17/06 , A61P19/10 , A61P35/00 , C07D417/12 , C07D417/14 , C07D471/04 , A61K31/428
Abstract: Benzothiazolyl derivatives (I), their enantiomers, diastereoisomers, and addition salts with acids and bases. Benzothiazolyl derivatives of formula (I), their enantiomers, diastereoisomers, and addition salts with acids and bases. X = O, S, CH2 or is CH linked to R ; Y = O or S; R and R = H, alkyl, aralkyl, aryloxy, arylalkyloxy, alkoxy, OH, amino, mono- and di-alkylamino; or R +R = oxo, thioxo, or imino; A = alkylene in which one methylene group may be replaced by O, S, or NH, N-alkyl, phenylene or naphthylene; B = alkylene, alkenylene, or alkynylene; D and D' = a benzene or pyridine ring, optionally substituted by 1-3 halo, CN, NO2, R, OR, -S(O)n-R, C(Z)R, -CH(OR)-R', C(Z)OR, NRR', C(Z)NRR', -CR=N-OR, -NR-C(Z)R', -NR-C(Z)OR', and OC(Me)2-COOR; R and R' = H, alkyl, alkenyl, alkynyl, aryl, aralkyl, heteroaryl, heteroarylalkyl, cycloalkyl, or cycloalkyl alkyl; Z = O or S; n = 0-2; R and R = H, halo, R, OR, or NRR'; or R +R = 5-6 membered ring that may contain O, N, or S; R = H, alkyl, alkenyl, alkynyl, aryl, heteroaryl, alkylcarbonyl, arylcarbonyl, or heteroaryl carbonyl, all of which may be substituted by one or more R , -CH2CHR R , -CH=CR R , halo, OH, NO2, CN, NH2 or alkoxy; R = -(CH2)t-C(=Z)Z'; t = 0-6; Z' = OR or NRR'; R and R = -C(=Z)Z' Where alkyl, alkoxy, alkylene, alkenyl, alkynyl, alkenylene and alkynylene groups have 1-6 C atoms, cycloalkyl groups have 3-8 C atoms, aryl means phenyl, naphthyl, or biphenyl, optionally partially hydrogenated, heteroaryl groups have one or two rings containing 5-10 members, optionally partially hydrogenated and containing 1-3 O, N and/or S atoms, and the aryl and heteroaryl groups may be substituted by 1-3 groups selected from alkyl, alkoxy, carboxy, formyl, amino, mono- and dialkylamino, ester, amido, NO2, CN, and OC(Me)2COOR.
-
公开(公告)号:HU0201646A2
公开(公告)日:2003-02-28
申请号:HU0201646
申请日:2002-05-14
Applicant: SERVIER LAB
Inventor: BENOIST ALAIN , BOULANGER MICHELLE , HUSSON-ROBERT BERNADETTE , LEVENS NIGEL , DE NANTEUIL GUILLAUME , NOSJEAN OLIVIER , PORTEVIN BERNARD
IPC: A61K31/40 , C07D295/10 , A61K31/426 , A61P3/04 , A61P3/08 , A61P3/10 , C07D207/16 , C07D277/04 , C07D277/06 , C07D295/185 , C07K5/02
Abstract: Alpha amino acid derivatives (I), their optical isomers and addition salts, are new. Alpha amino acid derivatives of formula (I), their optical isomers and addition salts, are new: A = five-membered heterocycle, optionally substituted by a cyano group; Ak = 1-6C alkylene; X = single bond or phenylene; R1, R2, R4 = H or 1-6C alkyl; Y = NR4 or CH-NO2; R3 = NO2 or CN; and provided that: (i) when Y is CH-NO2, then R3 may further be 1-6C alkyl; and (ii) when A is unsubstituted, then Ak is propylene, X is a bond, Y is NH and R3 is NO2, are excluded.
-
公开(公告)号:ZA200204865B
公开(公告)日:2003-02-20
申请号:ZA200204865
申请日:2002-06-18
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , FOURQUEZ JEAN-MARIE , LEVENS NIGEL , HUSSON-ROBERT BERNADETTE , NOSJEAN OLIVIER , BOULANGER MICHELLE
IPC: A61K31/16 , A61K31/397 , A61K31/40 , A61K31/403 , C07D295/18 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/04 , C07D277/22 , C07D295/185 , C07C , C07D , A61K , A61P
Abstract: A compound of formula (I):wherein:represents an optionally substituted saturated carbon ring having from 4 to 8 ring members,R1 and R4, which may be identical or different, each represents hydrogen or acyl,R2 and R3, which may be identical or different, each represents hydrogen or alkyl,R5 and R6, which may be identical or different, each represents hydrogen or alkyl, or R5 and R6 together, with the nitrogen atom carrying them, form an optionally substituted nitrogen-containing heterocycle,stereoisomers thereof, and also addition salts thereof with a pharmaceutically acceptable acid.Medicinal products containing the same which are useful for treatment of glucose intolerance or of disorders associated with hyperglycaemia.
-
公开(公告)号:ZA200202525B
公开(公告)日:2002-10-24
申请号:ZA200202525
申请日:2002-03-28
Applicant: SERVIER LAB
Inventor: NANTEUIL GUILLAUME DE , PORTEVIN BERNARD , BENOIST ALAIN , LEVENS NIGEL , NOSJEAN OLIVIER , HUSSON-ROBERT BERNADETTE
IPC: C07D295/18 , A61K31/40 , A61K31/4178 , A61K31/426 , A61K31/5377 , A61K38/00 , A61P1/00 , A61P1/02 , A61P3/04 , A61P3/10 , A61P31/18 , A61P35/00 , A61P37/06 , A61P43/00 , C07B57/00 , C07D207/16 , C07D231/04 , C07D233/06 , C07D233/48 , C07D277/04 , C07D277/06 , C07D277/10 , C07D295/22 , C07D403/12 , C07K5/062 , C07K5/078 , C07K5/087 , C07K5/097 , C07D , A61K , A61P
Abstract: Sulfonated amino acid derivatives (I), their optical isomers and acid addition salts, are new. Sulfonated amino acid derivatives (I), their optical isomers and acid addition salts, are new. ring A = a 5 membered nitrogen heterocycle that may be substituted by cyano; R1 = H, 1-6C alkyl or acyl, prolyl, alanyl, histidylprolyl, or phenylalanylprolyl; Ak = 1-6C alkylene or heteroalkylene; X = a bond or phenylene optionally substituted by one or more groups selected from halogens, 1-6C alkyl, alkoxy or polyhaloalkyl, or OH; R2 = 1-6C alkyl (optionally substituted by one or more groups selected from aryl, 1-6C alkylsulfonyl, 3-7C cycloalkylsulfonyl, 3-7C cycloalkyl, and halogen), 3-10C cycloalkyl, or a group -NR2aR2b; R2a and R2b = H, 1-6C alkyl, or together with the N atom they form a nitrogen heterocycle; Y = -NR3, -NH-CH=N-, -C(=NH)-NH-, or -NR4-C(=NR5)-NR6-; R3 = H, 1-6C alkyl, 3-7C cycloalkyl, or aryl; R4, R5, R6 = H, 1-6C alkyl; or R4 and R6 together, or R5 and R6 together = imidazolidine or dihydrobenzimidazole in which the term nitrogen heterocycle encompasses a monocyclic saturated ring of 5 - 7 members having 1 - 3 heteroatoms at least one of which is N and others may be N, O or S, and the term 1-6c alkylene encompasses a group that may be straight or branched and one methylene group may be replaced by an atom or O or S.
-
公开(公告)号:NO20022891D0
公开(公告)日:2002-06-17
申请号:NO20022891
申请日:2002-06-17
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , FOURQUEZ JEAN-MARIE , LEVENS NIGEL , HUSSON-ROBERT BERNADETTE , NOSJEAN OLIVIER , BOULANGER MICHELLE
IPC: A61K31/16 , C07D295/18 , A61K31/397 , A61K31/40 , A61K31/403 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/04 , C07D277/22 , C07D295/185 , C07D
Abstract: A compound of formula (I):wherein:represents an optionally substituted saturated carbon ring having from 4 to 8 ring members,R1 and R4, which may be identical or different, each represents hydrogen or acyl,R2 and R3, which may be identical or different, each represents hydrogen or alkyl,R5 and R6, which may be identical or different, each represents hydrogen or alkyl, or R5 and R6 together, with the nitrogen atom carrying them, form an optionally substituted nitrogen-containing heterocycle,stereoisomers thereof, and also addition salts thereof with a pharmaceutically acceptable acid.Medicinal products containing the same which are useful for treatment of glucose intolerance or of disorders associated with hyperglycaemia.
-
公开(公告)号:FR2815346A1
公开(公告)日:2002-04-19
申请号:FR0013125
申请日:2000-10-13
Applicant: SERVIER LAB
Inventor: FAUCHERE JEAN LUC , ORTUNO JEAN CLAUDE , LEVENS NIGEL , CHAMORRO SUZANNA , BOUTIN JEAN ALBERT
IPC: C07D249/14 , A61K31/4196 , A61K31/422 , A61K31/428 , A61K31/4439 , A61K31/4709 , A61K31/55 , A61P3/00 , A61P3/04 , A61P3/10 , A61P9/12 , A61P15/10 , A61P25/08 , A61P25/20 , A61P25/22 , A61P25/24 , A61P43/00 , C07D401/04 , C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/04 , A61K31/42
Abstract: Aminotriazolone derivatives (I) their enantiomers, diastereoisomers, and salts with acids and bases are new. Aminotriazolone derivatives (I) their enantiomers, diastereoisomers, and salts with acids and bases: R1 and R2 = H, 1-6C alkyl, 1-6C alkenyl, 1-6C alkynyl, aryl, heteroaryl, 3-8C cycloalkyl or heterocycloalkyl (all optionally substituted by OH, cycloalkyl, aryl, heteroaryl, heterocycloalkyl or halo); aryl = phenyl, naphthyl, biphenyl, dihydronaphthyl or tetrahydronaphthyl; R3 = H, 1-6C alkyl, 1-6C alkenyl, 1-6C alkynyl, aryl, heteroaryl ( mono- or bicyclic with 0-4 heteroatoms), 3-8C cycloalkyl or heterocycloalkyl (mono- or bicyclic with 0-4 heteroatoms) (all optionally substituted by OH, cycloalkyl, aryl, heteroaryl, heterocycloalkyl or halo); R4 = a group of formula (II); W = a bond or 1-6C alkylene; B = 3-10 membered mono- or polycyclic group (may be aromatic (optionally substituted by alkyl, alkoxy, halogen, OH, perhaloalkyl, NO2, amino (optionally substituted, acyl, aminocarbonyl, acylamino, alkoxycarbonyl, formyl, carboxy, sulfo, sulfino, sulfamoyl, nitrile, aminoalkyl, thioalkyl, or hydroxyalkyl) and may contain 1-3 hetero atoms (O, N, S) and contains at least one oxo), -COR or hydroxy group (may contain one or more unsaturations and one or more substituents (alkyl, alkoxy, OH, aryl, aralkyl, halo)); R = H, 1-6C alkyl, alkoxy, amino, alkylamino or dialkylamino; R5 = H or 1-6C alkyl; A = -A2-, -A1-A2-, -A2-A1- or -A1-A2-A1-; A1 = 1-6C alkylene, 1-6C alkenylene or 1-6C alkynylene; A2 = phenylene, naphthylene, 3-8C cycloalkylene, heteroarylene or heterocyclalkylene (all of which may be substituted by OH, cycloalkyl, aryl, heteroaryl, heterocycloalkyl or halo); V = a bond, -CH2-, -CO-, -CS-, -CH2NH- or -CH=N-; or V+R3 with -A- + -NR4- = -A-CH=N-R4. Provided that only one of R1 and R2 may be H.
-
公开(公告)号:NO322569B1
公开(公告)日:2006-10-30
申请号:NO20022285
申请日:2002-05-14
Applicant: SERVIER LAB
Inventor: BOULANGER MICHELLE , NANTEUIL GUILLAUME DE , PORTEVIN BERNARD , LEVENS NIGEL , BENOIST ALAIN , NOSJEAN OLIVIER , HUSSON-ROBERT BERNADETTE
IPC: C07D295/10 , A61K31/40 , A61K31/426 , A61P3/04 , A61P3/08 , A61P3/10 , C07D207/16 , C07D277/04 , C07D277/06 , C07D295/185 , C07K5/02
Abstract: Alpha amino acid derivatives (I), their optical isomers and addition salts, are new. Alpha amino acid derivatives of formula (I), their optical isomers and addition salts, are new: A = five-membered heterocycle, optionally substituted by a cyano group; Ak = 1-6C alkylene; X = single bond or phenylene; R1, R2, R4 = H or 1-6C alkyl; Y = NR4 or CH-NO2; R3 = NO2 or CN; and provided that: (i) when Y is CH-NO2, then R3 may further be 1-6C alkyl; and (ii) when A is unsubstituted, then Ak is propylene, X is a bond, Y is NH and R3 is NO2, are excluded.
-
-
-
-
-
-
-
-
-